Download ACE Update - Volume 13, No. 2: April 2013

April 2013
www.cancerexecutives.org
Food for thought: The importance of
NUTRITION for patients with cancer
By Abby C Sauer,
MPH, RD, LD,
Research Scientist, Abbott Nutrition
atients with cancer face many challenges, including
maintaining a good nutritional status and avoiding
weight loss and malnutrition. However, research shows
that the majority of patients with cancer suffer from various
nutritional deficits, and up to 85% of patients with certain
cancer types experience some form of weight loss and
malnutrition during their cancer treatment.1 For some patients,
the nutritional deficits can proceed to cancer cachexia, a
specific form of malnutrition characterized by loss of lean
body mass, muscle wasting, and impaired immune, physical,
and mental function.2 Furthermore, poor nutritional status,
weight loss, and malnutrition can lead to poor outcomes for
patients, including decreased quality of life, decreased
functional status, increased complication rates, and treatment
disruptions.1, 3, 4 Fortunately, providing early nutrition
intervention for patients can improve patients’ nutritional
status and help patients to maintain body weight, maintain
lean body mass, better tolerate treatment, and improve quality
of life.4-8 Therefore, all healthcare professionals who care for
patients with cancer need to recognize the signs of
malnutrition and be equipped to provide early and effective
nutrition intervention to improve outcomes.
P
Cancer and Nutritional Status
The continuum of cancer includes diagnosis, treatment,
recovery, and survivorship. Each stage in this continuum is
associated with specific challenges to patients and their
nutritional status. Both the cancer and its treatments can
have profound effects on an individual’s nutritional status,
making nutrition screening, assessment, and intervention a
vital component of medical care.
Changes in nutritional status may begin prior to diagnosis,
when physical and psychosocial issues commonly have a
negative impact on food intake. The reality is that at cancer
diagnosis, half of patients present with some form of nutritional deficit.9 This deterioration in nutritional status has been
found to poor outcomes, with as little as a 5% weight loss
predicting decreased response to therapy and decreased survival.1 Nutritional status also often declines during the natural
progression of cancer and its treatment, due to treatmentrelated side effects, and results in multiple and inter-related
nutritional issues.
One of the most significant nutritional issues that can arise
during cancer treatment is malnutrition. Malnutrition is defined
as a state of nutrition in which a deficiency, excess, or imbalance of energy, protein, and other nutrients causes measurable
adverse effects on body function and clinical
Figure 1: Impact of Malnutrition4
outcome.10 Malnutrition can result from the
disease process, from the use of cancer therapies, or from both. Side effects related to
common cancer therapies, including
chemotherapy, radiation, immunotherapy, and
surgery, are key contributors in promoting the
deterioration in nutritional status. The incidence of malnutrition in people with cancer
ranges from 30% to 87%.1, 11 Patients with
cancer of the lung, esophagus, stomach,
colon, rectum, liver, and pancreas are at
greatest risk.12 Of people who die from cancer, up to half have been malnourished.13 In
fact, up to 20% of patients die from the
effects of malnutrition rather than from the
cancer itself.14 Malnutrition leads to numerous negative outcomes including decreased
quality of life, increased complication rates,
decreased
treatment tolerance, and increased
Adapted with persmission from Marin-Caro M MM, Laviano A, Pichard C. Nutritional
mortality (see Figure 1).4
intervention and quality of life in adult oncology patients. Clin Nutr. 2007; 26: 289-301.
Continued on page 4 >
“theRecognize
signs of
malnutrition
and be
equipped to
provide early
and effective
nutrition
intervention
to improve
outcomes.
”
Calendar
20TH Annual Meeting
Jan. 29 – Feb. 1, 2014
San Francisco, CA
PA L A C E H O T E L
When is the best
time for a conversation
about nutrition?
We understand how
how hard
hard it is to fit nutrition into your plans. We
We can help mak
We
makee it a little easier
easier.
asierr..
Prescribe Nutrition to help improve
improve patient outcomes.
Prescribe
s )MPROVETREATMENTTOLERANCE
s )MPROVEQUALITYOFLIFE
s 2EDUCEUNPLANNEDHOSPITALIZATIONS
Additional products are available for your tube-fed patients.
Use under medical supervision.
eady have
have plenty to talk about. Let us help you ha
ve the nutrition conversation.
YYou
ou and your patients
pat
already
alr
have
TTalk
alk to your Abbott Nutrition Representative
Representative or visit www.abbottnutrition.com
www.abbottnutrition.com today
today..
tories Inc.
©2012 Abbott Labora
Laboratories
79829.003/October 2012 LITHO IN USA
www.abbottnutrition.com
www.abbottnutrition.com
References:
References: 1. Dewys WD, et al. Am J Med. 1980:69:491-497. 2. Halpern-Silveira D, et al. Support Care Cancer
Cancer.r. 2010;18:617-625. 3. Nayel
Nayel H, et al.
Nutrition
Nutrition.. 1992;8:13-18. 4. Isenring EA, Ca
Capra
pra S, Bauer JD. Br J Cancer
Cancer.r. 2004;91:447-452. 5. Marín Caro MM, et al. Clin Nutr
Nutr.r. 2007; 26:289-301.
6. Odelli C, et al. Clin Oncol. 2005;17:639-645. 7. Bauer JD, Capra
Capra S. Support Care Cancer
Cancer.r. 2005;13:270-274.
update
ASSOCIATION of CANCER EXECUTIVES |
www.cancerexecutives.org
APRIL 2013
Food for Thought: The
Importance of Nutrition
for Patients With Cancer
> Continued from page 1
Screening,
“
assessment and
intervention are
crucial to
preventing and
minimizing the
development of
malnutrition at all
stages of cancer
treatment
”
In addition to weight loss, cancer patients often experience
loss of lean body mass, or muscle mass. Loss of muscle
mass can result in similar outcomes as malnutrition and
includes decreased immunity, increased infections, increased
skin breakdown, decreased healing, and increased mortality.15 A study of head and neck cancer patients who were
starting nine weeks of treatment with concurrent chemotherapy and radiation and found that weight loss began one week
after the start of chemoradiation.16 On average, the subjects
lost almost 15 pounds over the course of treatment, and of
that weight loss, lean body mass accounted for 71%.16
In some patients, malnutrition can progress to cancer
cachexia which is “a multifactorial syndrome defined by an
ongoing loss of skeletal muscle mass (with or without loss of
fat mass) that cannot be fully reversed by conventional nutritional support and leads to progressive functional impairment.”2 Its pathophysiology is characterized by a negative
protein and energy balance driven by a variable combination
of reduced food intake and abnormal metabolism.2
Finally, nutrition remains important after treatment for cancer survivors. During survivorship, individuals are often highly
interested in diet and lifestyle modifications to prevent cancer
recurrence and to optimize their health. Cancer survivors
might also experience long-term or chronic side effects from
treatment, such as fatigue and saliva changes, that can continue to impact their food intake and nutritional status.
Research regarding the effects of diet, exercise, and body
weight on survivorship are in the early stages, and recommendations regarding the prevention of future cancer have
not been established.17 However, cancer survivors are encouraged to follow the same guidelines recommended for cancer
prevention including maintaining a healthy body weight, being
physically active, consuming a healthy diet rich in plant foods
and low in fat intake, and limiting alcohol intake.17, 18
Although all patients with cancer are at nutritional risk, not
all patients with cancer become malnourished or develop
cancer cachexia. Therefore, nutrition screening, assessment
and intervention are crucial to preventing and minimizing the
development of malnutrition at all stages of cancer treatment.
The Benefits of Nutrition Intervention
Many studies have demonstrated that maintaining a good
nutritional status through nutrition intervention can help individuals with cancer improve outcomes including:
• Increase energy and protein intake7, 19, 20
• Maintain and gain body weight5, 7, 8, 20
• Improve quality of life4, 20
• Improve strength and energy levels4
• Manage treatment-related side effects5
• Avoid dose reduction and treatment delays4, 8
• Reduce unplanned hospital admissions8
Continued on page 5 >
4
ASSOCIATION of CANCER EXECUTIVES |
update
www.cancerexecutives.org
APRIL 2013
Food for Thought: The
Importance of Nutrition
for Patients With Cancer
> Continued from page 4
It is
“
imperative that
the healthcare
team identify
patients early
so appropriate
nutrition
interventions
can be
implemented
”
Eating well during cancer treatment means including a
variety of foods every day to provide the nutrients (protein,
carbohydrate, fat, fluid, vitamins, and minerals) needed to
maintain health.17, 18 However, eating well is frequently a challenge because cancer and the side effects of treatment can
impact dietary intake and, ultimately, nutritional status.
Nutrition intervention in cancer patients can involve many
strategies, including dietary counseling and oral nutritional
supplementation. The goals of nutritional support in patients
with cancer are numerous and include maintaining an
acceptable weight and preventing or treating malnutrition,
leading to better tolerance of treatment and its side effects,
more rapid healing and recovery, reduced risk of infection
during treatment, and enhanced overall survival.4, 21, 22
Research has demonstrated that nutritional intervention in
cancer patients can result in positive outcomes. A recent systematic review and meta-analysis of oral nutritional interventions in malnourished cancer patients showed that nutritional
intervention, including nutritional counseling and oral nutritional supplementation, was associated with statistically significant improvements in weight and energy intake compared
with routine care and had a beneficial effect on some aspects
of quality of life.20 Additionally, another recent study showed
that patients undergoing chemo-radiotherapy for esophageal
cancer in a nutrition intervention program experienced better
outcomes than those who had received usual care. The
patients receiving nutrition intervention had greater treatment
completion rates, fewer unplanned hospital admissions and
those that were admitted to hospital had shorter length of
stay compared to the patients receiving usual care.8
Expert nutrition groups including the American Society for
Parenteral and Enteral Nutrition (ASPEN) and the European
Society for Clinical Nutrition and Metabolism (ESPEN) have
both issued clinical guidelines for nutritional treatment of
cancer patients. These guidelines state that cancer patients
should undergo nutrition screening and assessment and
receive early nutrition intervention to improve outcomes.21-22
Identifying At-Risk Patients and Providing
Appropriate Nutrition Intervention
Patients with cancer face many nutritional challenges including treatment-related side effects and weight loss. For many
of these patients, these challenges are present prior to cancer
diagnosis and can worsen during the course of treatment.
Therefore, it is imperative that the healthcare team identify
patients early so appropriate nutrition interventions can be
implemented to help improve the patients’ outcomes and
quality of life. The research and expert recommendations supports a preventive, rather than therapeutic, approach that
encompasses nutrition screening as early as possible and
treatment of nutritional problems through nutrition intervention.2, 14, 21-24 The ASPEN and ESPEN guidelines for nutrition in
cancer patients both recommend that nutritional screening
and assessment of cancer patients should be performed frequently and nutritional intervention should be initiated early
when deficits are identified.21, 22 The entire healthcare team
needs to work together to identify cancer patients at risk of
malnutrition early in order to plan the best possible intervention and follow-up during cancer treatment and progression.25
Summary
Poor nutritional status, weight loss, and malnutrition are common in patients with cancer. These nutritional challenges significantly increase morbidity and mortality in these patients,
and severe cases can lead to cancer cachexia. Early nutrition
screening and intervention is vital in these patients to help
prevent this nutritional decline and to help patients better tolerate their treatment regimen. Research has demonstrated
that early nutrition intervention, including oral nutritional supplementation, improves outcomes in cancer patients including
nutritional status, weight, treatment tolerance, and quality of
life. A multidisciplinary approach among all healthcare professionals involved in cancer care is necessary to identify at risk
patients early in the process and provide the appropriate and
effective nutritional interventions. ■
References
(1) DeWys WD, Begg C, Lavin PT et al. Prognostic
effect of weight loss prior to chemotherapy in cancer patients. Am J Med 1980;69:491-497.
(2) Fearon K, Strasser F, Anker SD et al. Definition
and classification of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489-495.
(3) Andreyev JHN, Norman AR, Oates J,
Cunningham D. Why do patients with weight loss
have a worse outcome when undergoing
chemotherapy for gastrointestinal malignancies?
Eur J Cancer 1998;34:503-509.
(4) Marin Caro MM, Laviano A, Pichard C.
Nutritional intervention and quality of life in adult
oncology patients. Clinical Nutrition 2007;26:289301.
(5) Nayel H, El-Ghonelmy E, El-Haddad S. Impact
of nutritional suppementation on treatment delay
and morbidity in patients with head and neck
tumors treated with irradiation. Nutrition
1992;8:13-18.
(6) Isenring EA, Capra S, Bauer JD. Nutrition
intervention is beneficial in oncology outpatients
receiving radiotherapy to the gastrointestinal or
head and neck area. British Journal of Cancer
2004;91:447-452.
(7) Bauer JD, Capra S, Battistutta D, Davidson W,
Ash S. Compliance with nutrition prescription
improves outcomes in patients with unresectable
pancreatic cancer. Clinical Nutrition 2005;24:9981004.
(8) Odelli C, Burgess D, Bateman L et al. Nutrition
support improves patient outcomes, treatment tolerance and admission characteristics in
oesophageal cancer. Clinical Oncology
2005;17:639--645.
(9) Halpern-Silveira D, Susin LRO, Borges LR,
Paiva SI, Assuncao MCF, Gonzalez MC. Body
weight and fat-free mass changes in a cohort of
patients receiving chemotherapy. Support Care
Cancer 2010;18:617-625.
(10) Guidelines for detection and management of
malnutrition: a report of the malnutrition advisory
group. Maidenhead, UK: British Association for
Parenteral and Enteral Nutrition (BAPEN); 2000.
(11) Heber D, Blackburn GL, Go VLW (eds).
Nutritional oncology. 1999.
(12) Capra S, Ferguson M, Ried K. Cancer: impact
of nutrition intervention outcome-nutrition issues
for patients. Nutrition 2001;17:769-772.
(13) Capra S, Bauer JD, Davidson W, Ash S.
Nutritional therapy for cancer-induced weight loss.
Nutr Clin Pract 2002;17:210-213.
(14) Ottery FD. Cancer cachexia: prevention, early
diagnosis, and management. Cancer Pract
1994;2:123-131.
(15) Demling RH. Nutrition, anabolism, and the
wound healing process. Eplasty 2009;9:65-94.
(16) Silver HJ, Dietrich MS, Murphy BA. Changes
in body mass, energy balance, physical function,
and inflammatory state in patients with locally
advanced head and neck cancer treated with concurrent chemoradiation after low-dose induction
chemotherapy. Head Neck 2007;29:893-900.
(17) Clinical Nutrition for Oncology Patients.
Sudbury, MA: Jones and Bartlett Publishers, LLC;
2010.
(18) Oncology Nutrition Dietetic Practice Group.
The Clinical Guide to Oncology Nutrition. 2nd
Edition ed. American Dietetic Association; 2006.
(19) Isenring EA, Bauer JD, Capra S. Nutrition
support using the American Dietetic Association
Medical Nutrition Therapy protocol for radiation
oncology patients improves dietary intake compared with standard practice. J Am Diet Assoc
2007;107:404-412.
(20) Baldwin C, Spiro A, Roger A, Emery PW. Oral
nutritional interventions in malnourished patients
with cancer: a systematic review and meta-analysis.
J Natl Cancer Inst 2012;104:1-15.
(21) August DA, Huhmann MB, and the American
Society for Parenteral and Enteral Nutrition
(ASPEN) Board of Directions. ASPEN clincial
guidelines: nutrition support therapy during adult
anticancer treatment and in hematopoeitic cell
transplantation. JPEN 2009;33:472-500.
(22) Arends J, Bodoky G, Bozzetti F et al. ESPEN
guidelines on enteral nutrition: non-surgical oncology. Clinical Nutrition 2006;25:245-259.
(23) Bauer JD, Capra S, Ferguson M. Use of the
scored Patient-Generated Subjective Global
Assessment (PG-SGA) as a nutrition assessment
tool in patients with cancer. European Journal of
Clinical Nutrition 2002;56:779-785.
(24) Kim JY, Wie GA, Cho YA, Kim SY, et al.
Development and validation of a nutrition screening
tool for hospital cancer patients. Clin Nutr
2011;doi:10.1016/j.clnu.2011.06.001:1-6.
(25) Santarpia L, Contaldo F, Pasanisi F. Nutrition
screening and early treatment of malnutrition in
cancer patients. J Cachexia Sarcopenia Muscle
2011;2(27):35.
5
Oncology
Cancer Compliance Specialists
With 35 years in the industry, CHAMPS Oncology provides
clients with personalized & specialized compliance
management services, including:
tCommission
t
Commission on Cancer Consulting
tCancer
t
Cancer Registry Management and Operations
t
Quality Control
tQuality
tCancer
t
Cancer Information Management
t
tAbstracting
Abstracting Assistance
tWorkflow
t
Workflow and Productivity Analysis
tCustomized
t
Customized Services
CHAMPS Oncology
@champshlthcare
www.champsoncology.com
ASSOCIATION of CANCER EXECUTIVES |
update
www.cancerexecutives.org
APRIL 2013
ACE MEMBER SPOTLIGHT
University of Texas M.D. Anderson Cancer Center
Submitted by Wendy Austin, RN, MS, AOCN, NEA-BC
M.D. Anderson Cancer Center
in Houston, Texas
How many years have you been an
oncology executive? 22 years
Organizational model of the center:
NCI-designated comprehensive cancer center;
M.D. Anderson is a University of Texas-affiliated
teaching hospital.
Annual new cancer cases/patients:
103,721 new patients and consults in fiscal
year 2012
Accreditations: The University of Texas
M.D. Anderson Cancer Center is accredited by
the Joint Commission and Health Organization,
the American College of Surgeons, and the
Commission on Colleges of the Southern
Association of Colleges and Schools.
Locations: M.D. Anderson’s main campus is in
the Texas Medical Center in Houston. We also
have four regional care centers in Greater
Houston, two research facilities in Bastrop
County, TX, two cobranded extensions in Arizona
and Florida that are fully integrated with local
hospitals to further our clinical and research
missions, three affiliates, nine certified members
whose quality management programs are based
on M.D. Anderson guidelines and best practices,
and an international network of 26 sister institutions that collaborate with us in grant-funded
research, student and faculty exchanges, and
annual conferences.
Unique or recently developed
programs/services: The Moon Shots
Program was launched in September 2012 to
dramatically accelerate the pace of translating
scientific discoveries into clinical advances that
reduce cancer deaths. The program targets six
areas: acute myeloid leukemia and myelodysplastic syndrome, chronic lymphocytic leukemia,
melanoma, lung cancer, prostate cancer, and
triple-negative breast and high-grade serous
ovarian cancers.
Lessons learned: Hire people who are
smarter than you and empower them to be their
best. Cancer is a team sport, and to win, it takes
a great coach and excellent players whose
unique contributions are acknowledged and
appreciated. It is an honor to be invited into
patients’ lives at this most critical time for
them—never forget or diminish that truth.
Contact information: (713) 792-7770 or
[email protected]
7
ASSOCIATION of CANCER EXECUTIVES |
update
www.cancerexecutives.org
APRIL 2013
19TH ANNUAL MEETING
JANUARY 23–26
SAN ANTONIO✯TEXAS
2013
G R A N D H YA T T S A N A N T O N I O
P O S T- M E E T I N G
Wrap-up
By Brian Mandrier, ACE Executive Director
he ACE 19th Annual Meeting was
held last January 23–26 at the Grand
Hyatt in San Antonio, TX. Attendees
were treated to three-plus days of excellent
weather, a great line-up of speakers end
educational sessions, and valuable
networking opportunities in the EXPO hall.
T
Wednesday, January 23
The day began with the Oncology 101 Pre-Conference Workshop.
Designed for those who are new to the oncology field, this one-day program preceded the ACE Annual Meeting. We were pleased to have more
than twenty attendees registered for this year’s Oncology 101. The program
featured several informative sessions including “Alphabet Soup,” presented
by Diane Cassels, Linda Ferris and Oncology 101 Chair Haylea Kenslea.
The day ended with the 19th Annual Meeting Welcoming Reception,
sponsored by Pyramid Healthcare Solutions. The reception brought together Oncology 101 attendees, annual meeting participants, exhibitors and
sponsors and was a great way to meet and greet colleagues and kick-off
the Annual Meeting.
Thursday, January 24
We were very pleased to have Ian Thompson, MD, as our
keynote speaker on Thursday. He discussed “Cancer
Management for an Aging Population” and he also gave
attendees a bit of behind the scenes tour of San Antonio
with his local knowledge. The day continued with sessions
on survivorship, rapid quality reporting, dealing with disruptive and unprofessional physicians. We were also very
pleased to launch the poster session format in San Antonio
with ten very informative posters. ACE will continue this format at
the 20th Annual Meeting in San Francisco next year. Thursday evening
concluded with a reception in the EXPO Hall. ACE was very pleased to
showcase thirty of the most innovative products and services to the industry and we hope to build on this success in the years to come.
Friday, January 25
Friday brought fantastic weather and more illuminating educational sessions to the Annual Meeting participants. A few brave attendees woke up
before the sun to take part in a morning workout along the famous River
Walk, arranged by ACE. Following an invigorating breakfast in the EXPO
hall, the session presenters covered more industry topics such as integrative therapy, patient navigation, transitional care coordination alignment
strategy and much more. Later that evening, several participants took part
in the dine-around program. It was a great time to join in conversations
with friends and colleagues while enjoying some of the River Walk’s many
exciting restaurants.
Saturday, January 26
The 2013–2014 ACE Committees began work early Saturday morning with
a breakfast discussion on the direction the committees will be taking ACE
over the next year. Later that morning we were very pleased to hear from
Abbott Nutrition’s platinum speaker Abby Sauer, MPH, RD, LD, who brought
attendees up to speed on current nutritional issues in oncology. The conference concluded with two very strong sessions on drug shortages and
oncology shared saving programs.
Acknowledgment and Looking Forward
As we close the books on another successful annual meeting, we give
thanks to the Education Committee led by Diane Cassels and the Vendor
Committee led by Dave Gosky — their work was instrumental in putting
together such a great meeting. We would also like to recognize the pivotal
support of the Annual Meeting exhibitors and the ACE Corporate Sponsors.
Without their continued participation such an event would not be possible.
We must now shift our gaze across the country to The City by the Bay.
Planning is already under way for the ACE 20th Annual Meeting to be held
January 29 – February 1, 2014 at the Palace Hotel in San Francisco, CA.
Mark your calendar and make plans to join us for this milestone ACE event!
Stay tuned to www.cancerexecutives.org throughout the year for
meeting updates and more information. ■
2013 ACE EXPO
Exhibitors
ACE thanks these companies for their
support and participation in the ACE 19th
Annual Meeting in San Antonio, Texas.
Abbott Nutrition
ACCC
Altos Solutions, Inc.
ACS Commission on Cancer
Brainlab
C/NET Solutions
CancerConnect.com
CHAMPS Oncology
Corporate Search, Inc.
D3 Oncology Solutions
Duke Realty
eHealth Technologies
Elekta
FKP Architects
GE Healthcare
Heery Design
Know Error
National Cancer Registrars
Association
Oncology Management
Consulting Group
Oncology Solutions
Philips Healthcare
Pyramid Healthcare Solutions
Radiation Business Solutions
Radiation Oncology Consulting
Reflectx Oncology Resources
Siemens Medical Solutions, Inc.
Sky Factory
Tensetic Systems Incorporated
The Oncology Group
Varian Medical Systems
8
Your budget for consulting
assistance may be limited...
But our ability to skillfully
assist you is not
# 3+ -/./
#1
.0++*-/ "4 "
#0)- .*!#*.+$/'*)*'*"4+-*"-(.N
*(+*(+- # ).$1
).$1 - ./
./ )
-.N( $'
)// -.N(
$'
*
)*'*"4)-$/$*)*)*'*"4+-/$ ..
*)*'*"4)-$/$*)*)*'*"4+-/$
)!)!- ./)$)"!$'$/$
./)$)"!$'$/$ ..-*../#
!*-
-*../# !*-
(
)44 -.b
-.b 2*-&'*.
42$/#4*0)
()44
2*-&'*. ''42$/#4*0)
44*0-/
*0-/ (T2$/#$)4*0-0"
(T2$/#$)4*0-0" //T/*-$)"
T/*-$)"
44*0/#
*0/# (*.//-"
(*.//-" / N(*./+-*!
N(*./+-*! ...$*)'
.$*)'
..0++*-//#/4*0-(*)
0++*-//#/4*0-(*) 4)04b
4)04b $)1$/
$)1$/ 44*0/*''0./87;T=<<T78>@~.&0.#*2
*0/*''0./87;T=<<T78>@~.&0.#*2
2 )#
+4*0A
)# ''+4*0A
OUP…
OMC GR
GROUP…
s,,
Outstandingg experts
experts,
Outstanding
ng rresults!
esults!
k$))$')-&
/)'4.
.
k
2
)/ -
1 '*+( )/
k*.+$/'[#4.$$)
)/
"-/$*)
k/-/
"$'))$)"
k+
-/$*)'..
..( )/.
k
1 )0 4' 1$ 2.
k
(+'
( )//$*))
)/
-$(
-.#$+
k
-!*-() )$))$'
)#(-&$)"
87;T=<<T78>@
*)*'*"4("(/b*(
.*'0/$*).C*)*'*"4("(/b*(
ASSOCIATION of CANCER EXECUTIVES |
update
www.cancerexecutives.org
APRIL 2013
PRESIDENT’S MESSSAGE
Diane Getchel Cassels, ACE President
Executive Administrator,
Winship Cancer Institute
hese are exciting times for the Association of Cancer
Executives as we celebrate our 20th anniversary. I am
honored to serve as your president during this milestone year and join the outstanding leaders that have represented us over the past two decades.
In order to look forward, I thought I would review the ACE
Mission and see how it applied to my own development and
how we can all be better mentors to those either just starting
in their career or to those of us who have to constantly learn
new skills. The mission as stated, is
T
“The Association of Cancer Executives (ACE)
is a national organization committed to the
leadership development of oncology executives
through continuing education and
professional networking designed to promote
improvement in patient care delivery.”
The key words for me are “leadership” and “networking.”
ACE members should be seen as those individuals having the
knowledge to lead cancer centers, hospital units and oncology services. How we get that knowledge depends on many
things, but for me, the main route has been through networking and involvement in professional societies.
Early in my management career, I was asked by a colleague to be a member of a committee of the Society of
Radiation Oncology Administrators (SROA). I was not only
honored, but flattered to be asked and thought of this as a
SAVE THE DATE
privilege. After a few years on committees, I was elected to
the Board of Directors and helped to shape the future of the
organization. Fellow committee members and board members became my “go to” contacts for when I was researching
an issue. I always felt that I could call someone and get a
straight answer. As I moved on into an academic administrative position, I then had new contacts and mentors to help
me learn the nuances of academic versus hospital practices.
If it wasn’t for those colleagues, I definitely would not be
where I am today.
I am sharing this with you today to make a few points.
First of all, the members of ACE are all colleagues willing to
share and help you succeed at whatever level you are in your
career. We may not pick up the phone as much as we used
to, but you can e-mail individuals or the entire membership
through the list-serve and get answers that you need. Our
web site will be going through some changes this year, led by
our member services committee. Let the committee know
what you would like to see on our site.
The second point is that in order to get the most out of
ACE, you need to get involved. There are not many organizations like ours where a member can get engaged on committees and rise to leadership in the organization in a short time.
The new Administrative Fellowship Program is designed to
cultivate executive leadership by promoting excellence and
enhancing the skills of individuals. This program was the
brain-child of a new member who attended ACE Oncology
101, outlined a fellowship program on the back of a napkin
and submitted this to the board for review. All of this happened within two years of him becoming a member. This
could not occur in a large bureaucratic organization!
Our Board of Directors is here to serve our members any
way we can. Please let us hear from you whenever you have
questions, concerns or new ideas. Every member should
make it their mission to enhance the organization and spread
the news to potential new members. There are still oncology
leaders out there that are not aware of ACE and the wonderful opportunities and benefits provided to its members.
Joining an ACE committee is also a great way to get further involved and stand out among your peers. Don’t hesitate
to reach out to our committee leaders to learn how you can
participate. Our new ACE committee chairs/co-chairs for
2013 are:
TH
2O
ANNUAL
MEETING
JAN. 29 – FEB. 1
2014
PA L A C E H O T E L
SAN FRANCISCO, CA
www.cancerexecutives.org
Linda Ferris, Bylaws & Election
Ted Yank, Education
Deena Gilland & Tammy McClanahan, Membership
Veronica Decker & Josh Schoppe, Member Services
Kelley Simpson, Newsletter/Publications
David Gosky & Teresa Heckel, Vendor Relations
A complete description of each committee and contact information is at www.cancerexecutives.org. ■
10
ASSOCIATION of CANCER EXECUTIVES |
update
www.cancerexecutives.org
APRIL 2013
!
*
&
COMMITTEE
JOIN A
Learn more about ACE Standing Committees at www.cancerexecutives.org
Or send us an email to . . . . . . . . . . . . . . . . . . . . . . . . . [email protected]
FEEDBACK
WE WANT YOUR
ACE appreciates your suggestions to better serve you.
Send your questions or comments to . . . . . . . . . . . . . . [email protected]
NEWS
ACHIEVEMENTS • PROGRAM CHANGES • EVENTS
SHARE YOUR
STAFF HONORS • TRANSITIONS • NEW FACILITIES
Announce it in ACE Update!
Send news and press releases to . . . . . . . . . . . . . . . . . [email protected]
ACE Update is published by Association of Cancer Executives | © 2013 Association of Cancer Executives. All rights reserved.
1025 Thomas Jefferson Street NW | Suite 500 East | Washington DC 20007 | 202 521 1886 | Fax 202 833 3636
www.cancerexecutives.org
11
ASSOCIATION of CANCER EXECUTIVES |
update
www.cancerexecutives.org
APRIL 2013
New Members
■ Mary-Kate Cellmer
Multi-Disciplinary Center Manager
Thomas Jefferson University Hospital
1015 Chestnut Street, Suite 622
Philadelphia, PA 19107
T: 215-503-6740
F: 215-955-1020
[email protected]
■ Laurie Henning
Practice Administrator
Hematology Oncology Associates, P.C.
2828 East Barnett Road
Medford, OR 97504
F: 541-842-4269
[email protected]
As of February 5, 2013
■ Stephen E Roth
Administrator, Cancer Institute
University of Mississippi Health Care
2500 North State Street, Suite G-751
Jackson, MS 39216
T: 601-815-6850
[email protected]
BUILT FOR COMPREHENSIVE CANCER CARE
■ John Hranicky
National Account Executive
Abbott Nutrition
3300 Stelzer Avenue
Columbus, OH 43219
T: 614-542-7532
[email protected]
■ Shreya Kanodia PhD
Associate Director, Administration
Samuel Oschin Comprehensive Cancer Insitute
Cedars-Sinai Medical Center
8700 Beverly Blvd., NT, Mezz C2003
Los Angeles, CA 90048
T: 310-423-3596
[email protected]
■ Tamara Keefe
Senior Brand Manager, Oncology
Abbott Nutrition
3300 Stelzer Road
102274 RP2-3
Columbus, OH 43219
T: 614-624-4307
[email protected]
■ Debbie Lewandowski
Assistant VP, Oncology Services
Martin Health System
501 E. Osceola Street
Robert & Carol Weissman Cancer Center
Stuart, FL 34994
T: 772-223-5945 x3717
F: 772-288-5871
[email protected]
At Duke Realty, we understand that cancer center
programs require a multidisciplinary team approach,
mutually benefiting the relationship between patients
and caregivers. Such programs require a facility
designed and built to support a comfortable and
healing environment with integrated technology.
For nearly 15 years, our physician and hospital
relationships have been focused on collaboration
to deliver innovative, effective oncology treatment
centers. We’ve developed both freestanding facilities,
such as the Outpatient Cancer Center for Baylor
University Health System in Dallas, Texas, as well as
cancer centers that are components of multi-tenant
medical buildings.
$1.3 Billion
Total value of Duke Realty’s
healthcare developments.
9
Number of cancer centers
developed and managed
by Duke Realty.
21
Years of experience
Duke Realty has in
healthcare specific
development.
When your hospital plans to expand its cancer care programs,
turn to Duke Realty. We’ll put our experience to work for you.
dukerealty.com/healthcare
12
ASSOCIATION of CANCER EXECUTIVES |
update
www.cancerexecutives.org
APRIL 2013
2012–2013 ACE Corporate Sponsors
P L AT I N U M
Contact ACE
to learn more
Thank you!
about our
Corporate
GOLD
GE Healthcare
CHAMPS Oncology
Oncology Management Consulting Group
Oncology Solutions
Heery Design
Know Error
Phillips Healthcare
Radiation Business
Solutions
Radiation Oncology
opportunities
BRONZE
S I LV E R
Accuray, Inc.
C/Net Solutions
Corporate Search
Duke Realty
eHealth Technologies
FKP Architects
Sponsorship
Consulting
The Oncology Group
Siemens Medical
Solutions, Inc.
ECG Management
Consultants
Meet Revenue and Compliance
Challenges of Tomorrow.
Get Proven Results Today!
Records review & auditing
Billing compliance
Procedural criteria for Medicare
Educational seminars
New construction/renovation consultations
Total management solutions
Addressing the Business of Radiation Oncology
Susan K. Vannoni, M.S., R.T. (R)(T) ROCC
Founder and CEO
[email protected]
(602) 291-7080
13